Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nyberg

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
World Journal of Urology|August 8, 2019
Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journeyJ Stranne, E Axen, I Franck-Lissbrant, et al.
The Journal of Urology|July 17, 2007
Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?Kathleen Joy Propert, Robert Mayer, J Curtis Nickel, et al.
The Journal of Urology|December 18, 2007
Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placeboKathleen Joy Propert, Robert Mayer, J Curtis Nickel, et al.
World Journal of Urology|August 19, 2007
Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG)Susan Keay, Jay E Reeder, Kristopher Koch, et al.
Urology|May 30, 2001
Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database studyJ E Tomaszewski, J R Landis, V Russack, et al.
The Journal of Urology|April 18, 2007
Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitisJ Curtis Nickel, Dean Tripp, Valerie Teal, et al.
Controlled Clinical Trials|April 12, 2003
Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trialOliver M Bautista, John W Kusek, Leroy M Nyberg, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirinMichael W Fried, Donald M Jensen, Maribel Rodriguez-Torres, et al.
Journal of Hepatology|November 28, 2012
Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosisSavino Bruno, John M Vierling, Rafael Esteban, et al.
American Journal of Obstetrics and Gynecology|June 26, 2003
Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in WomenJeanette S Brown, Leroy M Nyberg, John W Kusek, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
World Journal of Urology|August 8, 2019
Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journeyJ Stranne, E Axen, I Franck-Lissbrant, et al.
The Journal of Urology|July 17, 2007
Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?Kathleen Joy Propert, Robert Mayer, J Curtis Nickel, et al.
The Journal of Urology|December 18, 2007
Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placeboKathleen Joy Propert, Robert Mayer, J Curtis Nickel, et al.
World Journal of Urology|August 19, 2007
Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG)Susan Keay, Jay E Reeder, Kristopher Koch, et al.
Urology|May 30, 2001
Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database studyJ E Tomaszewski, J R Landis, V Russack, et al.
The Journal of Urology|April 18, 2007
Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitisJ Curtis Nickel, Dean Tripp, Valerie Teal, et al.
Controlled Clinical Trials|April 12, 2003
Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trialOliver M Bautista, John W Kusek, Leroy M Nyberg, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirinMichael W Fried, Donald M Jensen, Maribel Rodriguez-Torres, et al.
Journal of Hepatology|November 28, 2012
Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosisSavino Bruno, John M Vierling, Rafael Esteban, et al.
American Journal of Obstetrics and Gynecology|June 26, 2003
Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in WomenJeanette S Brown, Leroy M Nyberg, John W Kusek, et al.
Pageof 16